Source: Biomédica. Conference titles: Proceedings of the International Congress on Paracoccidioidomycosis. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOLINA, R. F. S et al. Alterations of granuloma architecture, cellularity and severity of the early infection in murine paracoccidioidomycosis by IFN-'alfa', celecoxib or lumiracoxib treatment. Biomédica. Bogotá: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2008APA
Molina, R. F. S., Nishikaku, A. S., Albe, B. P., & Burger, E. (2008). Alterations of granuloma architecture, cellularity and severity of the early infection in murine paracoccidioidomycosis by IFN-'alfa', celecoxib or lumiracoxib treatment. Biomédica. Bogotá: Instituto de Ciências Biomédicas, Universidade de São Paulo.NLM
Molina RFS, Nishikaku AS, Albe BP, Burger E. Alterations of granuloma architecture, cellularity and severity of the early infection in murine paracoccidioidomycosis by IFN-'alfa', celecoxib or lumiracoxib treatment. Biomédica. 2008 ; 28[citado 2024 out. 31 ]Vancouver
Molina RFS, Nishikaku AS, Albe BP, Burger E. Alterations of granuloma architecture, cellularity and severity of the early infection in murine paracoccidioidomycosis by IFN-'alfa', celecoxib or lumiracoxib treatment. Biomédica. 2008 ; 28[citado 2024 out. 31 ]
